{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreibbeacqqo7ailezyq5d3rrew4zndfcux2krwqs5odnvnhzxxrbdpe",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mks3k2ibyim2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreiadoha7mk3xzprnbjaiuwf2njz2ze3zqn5azibajtg5ckj4cvlzwe"
    },
    "mimeType": "image/jpeg",
    "size": 148527
  },
  "path": "/news/2026-05-cystatin-worse-heart-failure-outcomes.html",
  "publishedAt": "2026-05-01T08:00:02.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "Cystatin C (CysC) is an independent risk factor for adverse outcomes in patients with heart failure (HF) across the ejection fraction (EF) spectrum, according to a study published in Clinical Cardiology.",
  "title": "Cystatin C tied to worse heart failure outcomes across ejection fraction spectrum"
}